Brief: Cellect Biotechnology Reports Second Quarter Financial And Operating Results
12/08/2020 14:37
Aug 12 (Reuters) - Cellect Biotechnology Ltd APOP.O :
* CELLECT BIOTECHNOLOGY REPORTS SECOND QUARTER FINANCIAL AND
OPERATING RESULTS; FIRST HALF 2020 STRATEGIC DEVELOPMENTS CREATE
LONG-TERM REVENUE CATALYSTS
* Q2 LOSS PER SHARE $0.007
Source text for Eikon: ID:nPnTfg2Ga
Further company coverage: APOP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM